Erschienen in:
01.08.2019 | Case report
Abaloparatide
Various toxicities: 2 case reports
Erschienen in:
Reactions Weekly
|
Ausgabe 1/2019
Einloggen, um Zugang zu erhalten
Excerpt
A first-year review of abaloparatide use in a pharmacist-run anabolic osteoporosis clinic involving 31 patients described 2 women [ages not stated], of whom, one woman developed headache and dizziness, and other woman developed hip pain, weight gain and fatigue during anabolic osteoporosis therapy with SC abaloparatide [Tymlos] daily injections [doses, durations of treatments to reactions onsets and outcomes not stated]. …